# Building the blood-brain barrier: a scalable self-assembling 3D model of the brain microvasculature under unidirectional flow

**Authors:** Jade Admiraal, Promise O. Emeh, Marleen Bokkers, Sander P. M. de Ruiter, Thomas Olivier, Karla Queiroz, Todd P. Burton, Nienke R. Wevers

PMC · DOI: 10.1186/s12987-026-00765-x · Fluids and Barriers of the CNS · 2026-01-23

## TL;DR

A new 3D model of the blood-brain barrier allows researchers to study its function and test therapies for neurological diseases.

## Contribution

A scalable, self-assembling 3D BBB model with unidirectional flow and high-throughput capabilities is introduced.

## Key findings

- Human BBB vascular networks remain viable for at least 14 days with direct cell-cell interactions.
- Tri-cultures of endothelial cells, pericytes, and astrocytes show improved barrier function and vessel alignment.
- The model enables unidirectional perfusion without pumps, suitable for studying BBB function and therapies.

## Abstract

The blood vessels of the central nervous (CNS) system form a tight, protective blood-brain barrier (BBB). This barrier is essential for healthy CNS function but also poses a hurdle in the treatment of increasingly common neurological disorders. Additionally, BBB dysfunction is a hallmark of many neurological diseases, further emphasizing a need for a better understanding of BBB function in health and disease. We present a human self-assembling 3D model of the BBB in a microfluidic cell culture platform that allows culture of 48 models in parallel on one tissue culture plate. Human brain microvascular endothelial cells, pericytes, and astrocytes form highly reproducible BBB vascular networks under unidirectional perfusion and remain viable for a minimum of 14 days. Immunostaining reveals close cell-cell interactions with pericytes and astrocyte endfeet in direct contact with the brain microvasculature. Compared to endothelial monocultures, co-cultures with astrocytes or pericytes result in improved barrier function, lower vessel diameters, increased branching, and alignment of the vessels in the direction of fluid flow. These results were most pronounced in tri-cultures containing all three cell types. Unlike similar models previously reported, this brain microvasculature model allows for unidirectional perfusion without the need for pumps and syringes. Combined with its high-throughput nature, this feature renders the model suitable for studies of BBB function in health and disease, and assessment of potential BBB restorative therapies.

The online version contains supplementary material available at 10.1186/s12987-026-00765-x.

## Full-text entities

- **Genes:** PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, PGP (phosphoglycolate phosphatase) [NCBI Gene 283871] {aka AUM, G3PP, PGPase}, MBTPS1 (membrane bound transcription factor peptidase, site 1) [NCBI Gene 8720] {aka CAOP, PCSK8, S1P, SEDKF, SKI-1}, AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159] {aka CD140B, IBGC4, IMF1, JTK12, KOGS, OPDKD}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, RAPGEF5 (Rap guanine nucleotide exchange factor 5) [NCBI Gene 9771] {aka GFR, MR-GEF, MRGEF, REPAC}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}
- **Diseases:** neuroinflammation (MESH:D000090862), BBB dysfunction (MESH:C536830), Alzheimer's disease (MESH:D000544), Parkinson's disease (MESH:D010300), neurological disorders (MESH:D009461), Stroke (MESH:D020521), adult disability (MESH:D007859), neurological diseases (MESH:D020271), vascular dysfunction (MESH:D002561), death (MESH:D003643), multiple sclerosis (MESH:D009103), dementias (MESH:D003704)
- **Chemicals:** Triton X-100 (MESH:D017830), oxygen (MESH:D010100), methanol (MESH:D000432), Calcein-AM (MESH:C085925), FITC-Dextran (MESH:C015219), cyclosporin-A (MESH:D016572), Dextran (MESH:D003911), ECGM2 medium (-), glucose (MESH:D005947), formaldehyde (MESH:D005557), PBS (MESH:D007854), calcein (MESH:C007740), CO2 (MESH:D002245)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Mycoplasma (genus) [taxon 2093], Homo sapiens (human, species) [taxon 9606], Flavivirus [taxon 11051], Gallus gallus (bantam, species) [taxon 9031]
- **Cell lines:** HBMECs — Bos taurus (Bovine), Transformed cell line (CVCL_A1BE), HBMEC — Homo sapiens (Human), Transformed cell line (CVCL_0307)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12910996/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12910996/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12910996/full.md

---
Source: https://tomesphere.com/paper/PMC12910996